HIV vaccine to induce cytotoxic T cells recognizing conserved HIV-1/2-epitopes derived from the most frequent HLA types of the human population.

about

HIV vaccine to induce cytotoxic T cells recognizing conserved HIV-1/2-epitopes derived from the most frequent HLA types of the human population.

Item

http://www.wikidata.org/entity/Q39117522

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

HIV vaccine to induce cytotoxi ...... types of the human population.

@en

HIV vaccine to induce cytotoxi ...... types of the human population.

@nl

type

Item

label

HIV vaccine to induce cytotoxi ...... types of the human population.

@en

HIV vaccine to induce cytotoxi ...... types of the human population.

@nl

prefLabel

HIV vaccine to induce cytotoxi ...... types of the human population.

@en

HIV vaccine to induce cytotoxi ...... types of the human population.

@nl

P1476

HIV vaccine to induce cytotoxi ...... types of the human population.

@en

P2093

Eszter Somogyi

http://www.w3.org/2001/XMLSchema#string

Julianna Lisziewicz

http://www.w3.org/2001/XMLSchema#string

P2860

Design and pre-clinical evaluation of a universal HIV-1 vaccine

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.

Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.

Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.

Diversity considerations in HIV-1 vaccine selection.

Design and tests of an HIV vaccine.

TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection

P304

825-828

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT.13.79

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

254259575

http://www.w3.org/2001/XMLSchema#string

P698

23902551

http://www.w3.org/2001/XMLSchema#string